gms | German Medical Science

76. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

04.05. - 08.05.2005, Erfurt

Validation of the Sino-Nasal Outcome Test 20 German Adapted Version (SNOT-20 GAV) for Measuring Quality of Life (QOL) in Patients with Chronic Rhinosinusitis (CRS)

Meeting Abstract

  • corresponding author Ingo Baumann - Department of Otolaryngology, Head & Neck Surgery, University of Heidelberg, Heidelberg
  • author Gunnar Blumenstock - Department of Medical Information Processing, University of Tuebingen, Tuebingen
  • author Harry De Maddalena - Section of Phoniatry and Pedaudiology at the Department of Otolaryngology, Head & Neck Surgery, University of Tuebingen, Tuebingen
  • author Peter K. Plinkert - Department of Otolaryngology, Head & Neck Surgery, University of Heidelberg, Heidelberg
  • author Jay F. Piccirillo - Clinical Outcomes Research Office, Department of Otolaryngology, Head & Neck Surgery, Washington University School of Medicine, St. Louis, MO, USA

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 76. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V.. Erfurt, 04.-08.05.2005. Düsseldorf, Köln: German Medical Science; 2005. Doc05hno100

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/hno2005/05hno209.shtml

Veröffentlicht: 22. September 2005

© 2005 Baumann et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Introduction: Up to now no validated German instrument for measuring health-related QOL in patients with CRS was at disposal.

Methods: The SNOT-20 GAV is a translated and adapted version of the Sino-Nasal Outcome Test 20 (SNOT-20, Piccirillo, 2002). Beside the General Score (GS) three subscores exist in the German Version: Primary Nasal Symptoms (PNS), Secondary Rhinogenous Symptoms (SRS) and General Quality of Life (GQOL). To validate the instrument we evaluated reliability (internal consistency and test-retest-reliability), validity (content validity, discrimination validity) and sensitivity to change [Standardized Response Mean (SRM)and Effect Size (ES)].

The SNOT-20 GAV was completed by 163, 123, and 82 patients at the initial visit and at 3 months and 1 year after treatment commencement.

Results: Cronbach‘s ά was >0.7 in three out of four scores. Test-retest-scores in 38 patients were highly correlated [from 0.525 (PNS) to .876 (GQOL)]. Discrimination validity was demonstrated by a comparison with healthy controls. SRM and ES showed medium to large effects.

Conclusions: The SNOT-20 GAV is the first reliable, valid and sensitive German instrument for measuring health-related QOL in patients with CRS.